Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Immunosuppressive treatments in multiple sclerosis
Darin T. Okuda
Neurology & Neurotherapeutics - NE Multiple Sclerosis Section
Neurology & Neurotherapeutics
Research output
:
Contribution to journal
›
Article
›
peer-review
22
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immunosuppressive treatments in multiple sclerosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Multiple Sclerosis
100%
Immunosuppressive Agents
94%
United States Food and Drug Administration
32%
Autoimmune Diseases of the Nervous System
24%
Glatiramer Acetate
23%
Mycophenolic Acid
18%
Therapeutics
18%
Azathioprine
17%
Immunologic Factors
17%
Methotrexate
15%
Cyclophosphamide
15%
Interferons
14%
Magnetic Resonance Imaging
10%
Technology
10%
Safety
9%